Logo image
Back
Pancreatic mucinous cystic neoplasm in a transgender patient
Journal article   Open access   Peer reviewed

Pancreatic mucinous cystic neoplasm in a transgender patient

Deshka Foster, Mohammad F Shaikh, Elizabeth Gleeson, Blake D Babcock, Jianping Lin, Robert T Ownbey, Mark E Hysell, Daniel Ringold and Wilbur B Bowne
World journal of surgical oncology, v 13(1), pp 205-205
24 Jun 2015
DOI: https://doi.org/10.1186/s12957-015-0620-8
PMID: 26104783
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1186/s12957-015-0620-8View
Published, Version of Record (VoR)CC BY V4.0,  Open

Abstract

Adult Cystadenoma, Mucinous - pathology Cystadenoma, Mucinous - surgery Female Humans Male Pancreatectomy Pancreatic Neoplasms - pathology Pancreatic Neoplasms - surgery Prognosis Transgender Persons
Cystic pancreatic lesions are increasingly more frequent detected clinical entities. Mucinous cystic neoplasm (MCN) is a hormone-related pancreatic tumor (HRTP) with a strong predominance in young and middle-aged females. Here, we present the case of a 31-year-old surgically transgendered female-to-male patient with a history of alcoholic pancreatitis, on chronic testosterone therapy. He was found to have a pancreatic MCN and underwent distal pancreatectomy and splenectomy. To our knowledge, this is the first reported case of a transgender patient with a history of hormone replacement therapy (HRT) and pancreatic MCN. We consider possible mechanisms for the pathogenesis to explain this patient's neoplasm.

Metrics

4 Record Views
4 citations in Web of Science
3 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Oncology
Surgery
Logo image